WuXi AppTec Co., Ltd. (603259.SS)
CNY 56.05
(-0.09%)
CNY 56.05
(-0.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 14.16 Billion CNY | 5.56% |
| 2022 | 12.78 Billion CNY | 76.47% |
| 2021 | 7.74 Billion CNY | 57.09% |
| 2020 | 4.8 Billion CNY | 38.6% |
| 2019 | 3.26 Billion CNY | 2.68% |
| 2018 | 3.25 Billion CNY | 47.05% |
| 2017 | 1.79 Billion CNY | 23.69% |
| 2016 | 1.51 Billion CNY | 50.13% |
| 2015 | 1.15 Billion CNY | 67.55% |
| 2014 | 692.75 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 3.15 Billion CNY | 29.03% |
| 2024 Q3 | 2.84 Billion CNY | -9.84% |
| 2024 Q1 | 2.44 Billion CNY | -25.64% |
| 2023 FY | - CNY | 5.56% |
| 2023 Q4 | 3.29 Billion CNY | -1.24% |
| 2023 Q3 | 3.33 Billion CNY | -19.54% |
| 2023 Q1 | 2.51 Billion CNY | -20.32% |
| 2023 Q2 | 4.14 Billion CNY | 64.9% |
| 2022 Q2 | 3.61 Billion CNY | 75.76% |
| 2022 FY | - CNY | 76.47% |
| 2022 Q4 | 3.15 Billion CNY | 39.6% |
| 2022 Q3 | 2.25 Billion CNY | -37.49% |
| 2022 Q1 | 2.05 Billion CNY | 101.48% |
| 2021 Q4 | 1.02 Billion CNY | -38.29% |
| 2021 FY | - CNY | 57.09% |
| 2021 Q3 | 1.65 Billion CNY | -6.06% |
| 2021 Q2 | 1.76 Billion CNY | 15.88% |
| 2021 Q1 | 1.51 Billion CNY | 42.61% |
| 2020 Q2 | 1.5 Billion CNY | 181.53% |
| 2020 Q1 | 536.11 Million CNY | 247.82% |
| 2020 FY | - CNY | 38.6% |
| 2020 Q4 | 1.06 Billion CNY | 44.44% |
| 2020 Q3 | 737.44 Million CNY | -51.14% |
| 2019 Q1 | 644.03 Million CNY | -37.76% |
| 2019 FY | - CNY | 2.68% |
| 2019 Q4 | 154.13 Million CNY | -84.26% |
| 2019 Q3 | 979.28 Million CNY | 46.63% |
| 2019 Q2 | 667.85 Million CNY | 3.7% |
| 2018 Q3 | 576.52 Million CNY | -2.15% |
| 2018 Q1 | 495.47 Million CNY | 1.43% |
| 2018 Q2 | 589.19 Million CNY | 18.91% |
| 2018 FY | - CNY | 47.05% |
| 2018 Q4 | 1.03 Billion CNY | 79.48% |
| 2017 Q3 | 435.67 Million CNY | -16.33% |
| 2017 Q1 | 436.38 Million CNY | 0.0% |
| 2017 FY | - CNY | 23.69% |
| 2017 Q4 | 488.49 Million CNY | 12.12% |
| 2017 Q2 | 520.69 Million CNY | 19.32% |
| 2016 FY | - CNY | 50.13% |
| 2015 FY | - CNY | 67.55% |
| 2014 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 1.11 Billion CNY | -1172.261% |
| Joinn Laboratories(China)Co.,Ltd. | 639.51 Million CNY | -2115.6% |
| Autobio Diagnostics Co., Ltd. | 1.87 Billion CNY | -656.594% |
| Thalys Medical Technology Group Inc. | -23.79 Million CNY | 59650.786% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 1.33 Billion CNY | -964.006% |
| Chemclin Diagnostics Co., Ltd. | 219.33 Million CNY | -6359.913% |